Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study

Journal:

American Journal of Respiratory and Critical Care Medicine

Published:

2026-05-19

DOI:

10.1093/ajrccm/aamag225

Affiliations:

9

Authors:

10

Go to article

Institutions	Authors	Share
AstraZeneca Gaithersburg, MD, United States of America (USA)	2.000000	0.20
Amgen, United States of America (USA)	2.000000	0.20
AstraZeneca Spain, Spain	1.000000	0.10
University of Wisconsin-Madison (UW-Madison), United States of America (USA)	1.000000	0.10
University of California, San Diego (UC San Diego), United States of America (USA)	1.000000	0.10
Washington University in St. Louis (WUSTL), United States of America (USA)	1.000000	0.10
Howard University, United States of America (USA)	1.000000	0.10
University of Michigan (U-M), United States of America (USA)	1.000000	0.10

Interested in Cardiovascular Medicine and Haematology?